title: Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.
authors.affiliation: Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.
authors.forename: Ross A
authors.initials: RA
authors.lastname: Abrams
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Lowy
authors.forename: Eileen M
authors.initials: EM
authors.lastname: O'Reilly
authors.forename: Robert A
authors.initials: RA
authors.lastname: Wolff
authors.forename: Vincent J
authors.initials: VJ
authors.lastname: Picozzi
authors.forename: Peter W T
authors.initials: PW
authors.lastname: Pisters
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D012107:Research Design
chemical_list: D000970:Antineoplastic Agents